| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |